This observation and subsequent case report has since been validated through preclinical modeling, in which patient-derived xenografts of CCDC6-RET-fusion positive NSCLC show multiple mutations at G810 in recurrent tumors [96]. The gene discussed is RET; the disease is non-small cell lung carcinoma.